Selected research
Industry Research
Amikacin Industry Research Report 2026
Market perspective
The global Amikacin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Amikacin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Amikacin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Amikacin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Amikacin include TNJ Chemical, Tuochukangyuan Pharm., 3B Scientific, Shenglide Biology, Bide Pharm., TargetMol, Pure Chemistry Scientific, OChem and MuseChem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Amikacin market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Amikacin Market by Company
TNJ Chemical
Tuochukangyuan Pharm.
3B Scientific
Shenglide Biology
Bide Pharm.
TargetMol
Pure Chemistry Scientific
OChem
MuseChem
Mucule
Inter Bio Screen
Clearsynth
Biosynth
Angene
Amikacin Segment by Type
98% Purity Type
99% Purity Type
99.8% Purity Type
Others
Amikacin Segment by Application
Amikacin Eye Drops
Amikacin Injection
Others
Amikacin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amikacin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amikacin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amikacin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Amikacin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Amikacin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Amikacin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 98% Purity Type
- 99% Purity Type
- 99.8% Purity Type
- Others
Applications
- Amikacin Eye Drops
- Amikacin Injection
- Others
Companies covered
- TNJ Chemical
- Tuochukangyuan Pharm.
- 3B Scientific
- Shenglide Biology
- Bide Pharm.
- TargetMol
- Pure Chemistry Scientific
- OChem
- MuseChem
- Mucule
- Inter Bio Screen
- Clearsynth
- Biosynth
- Angene
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Amikacin Market Size (2021-2032)
- 2.2.2 Global Amikacin Sales (2021-2032)
- 2.2.3 Global Amikacin Market Average Price (2021-2032)
- 2.3 Amikacin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 98% Purity Type
- 2.3.3 99% Purity Type
- 2.3.4 99.8% Purity Type
- 2.3.5 Others
- 2.4 Amikacin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Amikacin Eye Drops
- 2.4.3 Amikacin Injection
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Amikacin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Amikacin Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Amikacin Revenue of Manufacturers (2021-2026)
- 3.4 Global Amikacin Average Price by Manufacturers (2021-2026)
- 3.5 Global Amikacin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Amikacin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Amikacin, Product Type & Application
- 3.8 Global Manufacturers of Amikacin, Established Date
- 3.9 Global Amikacin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 TNJ Chemical
- 4.1.1 TNJ Chemical Company Information
- 4.1.2 TNJ Chemical Business Overview
- 4.1.3 TNJ Chemical Amikacin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 TNJ Chemical Amikacin Product Portfolio
- 4.1.5 TNJ Chemical Recent Developments
- 4.2 Tuochukangyuan Pharm.
- 4.2.1 Tuochukangyuan Pharm. Company Information
- 4.2.2 Tuochukangyuan Pharm. Business Overview
- 4.2.3 Tuochukangyuan Pharm. Amikacin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Tuochukangyuan Pharm. Amikacin Product Portfolio
- 4.2.5 Tuochukangyuan Pharm. Recent Developments
- 4.3 3B Scientific
- 4.3.1 3B Scientific Company Information
- 4.3.2 3B Scientific Business Overview
- 4.3.3 3B Scientific Amikacin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 3B Scientific Amikacin Product Portfolio
- 4.3.5 3B Scientific Recent Developments
- 4.4 Shenglide Biology
- 4.4.1 Shenglide Biology Company Information
- 4.4.2 Shenglide Biology Business Overview
- 4.4.3 Shenglide Biology Amikacin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Shenglide Biology Amikacin Product Portfolio
- 4.4.5 Shenglide Biology Recent Developments
- 4.5 Bide Pharm.
- 4.5.1 Bide Pharm. Company Information
- 4.5.2 Bide Pharm. Business Overview
- 4.5.3 Bide Pharm. Amikacin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bide Pharm. Amikacin Product Portfolio
- 4.5.5 Bide Pharm. Recent Developments
- 4.6 TargetMol
- 4.6.1 TargetMol Company Information
- 4.6.2 TargetMol Business Overview
- 4.6.3 TargetMol Amikacin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 TargetMol Amikacin Product Portfolio
- 4.6.5 TargetMol Recent Developments
- 4.7 Pure Chemistry Scientific
- 4.7.1 Pure Chemistry Scientific Company Information
- 4.7.2 Pure Chemistry Scientific Business Overview
- 4.7.3 Pure Chemistry Scientific Amikacin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pure Chemistry Scientific Amikacin Product Portfolio
- 4.7.5 Pure Chemistry Scientific Recent Developments
- 4.8 OChem
- 4.8.1 OChem Company Information
- 4.8.2 OChem Business Overview
- 4.8.3 OChem Amikacin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 OChem Amikacin Product Portfolio
- 4.8.5 OChem Recent Developments
- 4.9 MuseChem
- 4.9.1 MuseChem Company Information
- 4.9.2 MuseChem Business Overview
- 4.9.3 MuseChem Amikacin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 MuseChem Amikacin Product Portfolio
- 4.9.5 MuseChem Recent Developments
- 4.10 Mucule
- 4.10.1 Mucule Company Information
- 4.10.2 Mucule Business Overview
- 4.10.3 Mucule Amikacin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Mucule Amikacin Product Portfolio
- 4.10.5 Mucule Recent Developments
- 4.11 Inter Bio Screen
- 4.11.1 Inter Bio Screen Company Information
- 4.11.2 Inter Bio Screen Business Overview
- 4.11.3 Inter Bio Screen Amikacin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Inter Bio Screen Amikacin Product Portfolio
- 4.11.5 Inter Bio Screen Recent Developments
- 4.12 Clearsynth
- 4.12.1 Clearsynth Company Information
- 4.12.2 Clearsynth Business Overview
- 4.12.3 Clearsynth Amikacin Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Clearsynth Amikacin Product Portfolio
- 4.12.5 Clearsynth Recent Developments
- 4.13 Biosynth
- 4.13.1 Biosynth Company Information
- 4.13.2 Biosynth Business Overview
- 4.13.3 Biosynth Amikacin Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Biosynth Amikacin Product Portfolio
- 4.13.5 Biosynth Recent Developments
- 4.14 Angene
- 4.14.1 Angene Company Information
- 4.14.2 Angene Business Overview
- 4.14.3 Angene Amikacin Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Angene Amikacin Product Portfolio
- 4.14.5 Angene Recent Developments
5 Global Amikacin Market Scenario by Region
- 5.1 Global Amikacin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Amikacin Sales by Region: 2021-2032
- 5.2.1 Global Amikacin Sales by Region: 2021-2026
- 5.2.2 Global Amikacin Sales by Region: 2027-2032
- 5.3 Global Amikacin Revenue by Region: 2021-2032
- 5.3.1 Global Amikacin Revenue by Region: 2021-2026
- 5.3.2 Global Amikacin Revenue by Region: 2027-2032
- 5.4 North America Amikacin Market Facts & Figures by Country
- 5.4.1 North America Amikacin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Amikacin Sales by Country (2021-2032)
- 5.4.3 North America Amikacin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Amikacin Market Facts & Figures by Country
- 5.5.1 Europe Amikacin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Amikacin Sales by Country (2021-2032)
- 5.5.3 Europe Amikacin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Amikacin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Amikacin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Amikacin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Amikacin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Amikacin Market Facts & Figures by Country
- 5.7.1 South America Amikacin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Amikacin Sales by Country (2021-2032)
- 5.7.3 South America Amikacin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Amikacin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Amikacin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Amikacin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Amikacin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Amikacin Sales by Type (2021-2032)
- 6.1.1 Global Amikacin Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Amikacin Sales Market Share by Type (2021-2032)
- 6.2 Global Amikacin Revenue by Type (2021-2032)
- 6.2.1 Global Amikacin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Amikacin Revenue Market Share by Type (2021-2032)
- 6.3 Global Amikacin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Amikacin Sales by Application (2021-2032)
- 7.1.1 Global Amikacin Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Amikacin Sales Market Share by Application (2021-2032)
- 7.2 Global Amikacin Revenue by Application (2021-2032)
- 7.2.1 Global Amikacin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Amikacin Revenue Market Share by Application (2021-2032)
- 7.3 Global Amikacin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Amikacin Value Chain Analysis
- 8.1.1 Amikacin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Amikacin Production Mode & Process
- 8.2 Amikacin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Amikacin Distributors
- 8.2.3 Amikacin Customers
9 Global Amikacin Analyzing Market Dynamics
- 9.1 Amikacin Industry Trends
- 9.2 Amikacin Industry Drivers
- 9.3 Amikacin Industry Opportunities and Challenges
- 9.4 Amikacin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst